What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Guanidinoacetic Acid Market Size, Share, Growth, And Global Industry Growth By Type (Feed Grade, Pharmaceutical Grade, and others), By Application (Fodder, Medicine, and others), Covid-19 Impact, Latest Trends, Segmentation, Driving Factors, Restraining Factors, Key Industry Players, Regional Insights and Forecast From 2025 To 2034
Trending Insights

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
GUANIDINOACETIC ACID MARKET OVERVIEW
The Global Guanidinoacetic Acid Market is projected to reach USD 0.037 billion in 2025, grow further to about USD 0.039 billion in 2026, and is anticipated to achieve nearly USD 0.056 billion by 2034, progressing at a CAGR of 4.3% during 2025–2034.
Guanidinoacetic acid, also known as glycocyamine, is a derivate of glycine and L arginine. The foremost role of guanidinoacetic acid is to synthesize creatine which plays a crucial role in the metabolism of the body. Creatine is a natural compound which is stored in the skeletal muscle of the body and helps in maintaining a quality of life and improves muscle strength. The acid has found its importance in the field of animal husbandry and continuous research has shown that using guanidinoacetic in animal fodder promotes muscle health and contributes to an overall healthy metabolism in the animals.
The consumerist culture has seen a transformation in ideologies. Most people opt for quality-driven products rather than quantity. Previously, not many people were interested in enlightening themselves about the quality of the quantity served. The contemporary world is moving towards sustainable living. As a result, quality is being ensured in every field. Animal husbandry in which a majority of the population depends on meat and dairy supplements is being regulated and animal health is a major concern. Guanidinoacetic acid provides nutrition and nourishes the health of the animal which results in quality meat to cope with the rising living standards. Human beings' supplements containing guanidinoacetic acid advantageous in releasing fatigue and good muscle health. The rise in living standards and intake of supplements will drive the growth of guanidinoacetic acid market size in the forecasted year.
Key Findings
- Market Size and Growth: The Global Guanidinoacetic Acid Market is projected to reach USD 0.037 billion in 2025, grow further to about USD 0.039 billion in 2026, and is anticipated to achieve nearly USD 0.056 billion by 2034, progressing at a CAGR of 4.3% during 2025–2034.
- Key Market Driver: Rising investment in health-friendly products contributes approximately 40% to market growth, as demand for supplements and quality animal feed increases.
- Major Market Restraint: Adverse side effects, including potential cardiovascular issues and neurotoxicity, restrict nearly 20% of market adoption globally.
- Emerging Trends: Continuous research and innovation, such as combining guanidinoacetic acid with betaine, is increasing efficacy and endurance by 30%, driving adoption in both human supplements and animal feed.
- Regional Leadership: Asia Pacific leads the market with 45% share due to high population, manufacturing capacity, and key local players in China and India.
- Competitive Landscape: Top companies like Evonik, Tiancheng Chempharm, and Jiangsu Yuanyang hold approximately 50% of the market through new product launches, partnerships, and strategic expansions.
- Market Segmentation: Feed grade dominates the type segment with 60% share, while fodder applications account for 55% of the usage; pharmaceutical grade and medicine applications make up the remainder.
- Recent Development: Expansion of manufacturing units and R&D facilities in China and Germany has increased production capacity by 25% and strengthened market supply chains.
COVID-19 Impact
Supply Chain Hurdles and Frequent Lockdowns Dented Market Prospects
The global COVID-19 pandemic has been unprecedented and staggering, with the guandinoacetic market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The spike in CAGR is attributable to the guanidinoacetic acid market growth and demand returning to pre-pandemic levels once the pandemic is over.
COVID-19's sudden emergence had a huge impact on all industrial sectors. The world was not prepared for a pandemic and it resulted in the slowdown of the market. The COVID-19 had affected China - a key player in guanidinoacetic acid market growth. The global lockdowns, shutting down of manufacturing units, and labor shortage directly affected the supply chain and there was a dearth of raw materials which retarded the market growth. However, as the world gears up for the normalization phase with a health-conscious mindset, a substantial guanidinoacetic acid market growth is anticipated in the forthcoming years.
LATEST TRENDS
Continuous Innovation to Accelerate the Product Demand
Guanidinoacetic acid is an experimental product and continuous research and innovations are being carried out by scientists to explore it further. Although it has shown tremendous impact in maintaining good muscle health and releasing fatigue, there are some shortcomings which pose a concern. The latest observation states that the incorporation of betaine with guanidinoacetic helps in chronic illness, less fatigue, high endurance and overall wellbeing. It has also shown visible improvements in the symptoms of arthritis and asthma, and glucose tolerance in diabetic and non-diabetic patients. Expanding scope of research and development surrounding the product will create favorable market opportunities in the forthcoming years.
- Incorporation of betaine with guanidinoacetic acid has shown over 30% improvement in endurance and reduced fatigue in both human and animal studies (Journal of Animal Science, 2023).
- Expansion of R&D and manufacturing facilities in China and Germany has increased production capacity by 25%, enhancing global supply chains (Food and Agriculture Organization – FAO, 2023).
GUANIDINOACETIC ACID MARKET SEGMENTATION
-
By Type
Based on type, the market is divided into feed grade, pharmaceutical grade, and others. Feed grade is expected to hold the largest market share during the period 2022-2028.
-
By Application
Based on the application, the market is divided into fodder, medicine, and others. The fodder segment is anticipated to hold the dominant market share in the forthcoming years.
DRIVING FACTORS
Rising Investment in Health-Friendly Products to Drive Product Sales
COVID-19 exposed the worst health crisis of modern times. The pandemic has changed the consumerist market. Sustainable living is a trend now and it will continue to affect all forms of consumption. Health is a major concern and to keep up with good immunity, people are looking forward to health supplements which will make up for the nutrient deficiency and boost metabolism. Animal husbandry has also upgraded its mechanism and looks after the health of the animal which will give quality meat and other products. The ongoing health crisis compelled people to choose a product which is good for their body and environmentally friendly. The pandemic has been a lifelong lesson and consumers are investing their money in authentic health-friendly products. This will be a major driving factor for the growth of guanidinoacetic acid market share in the future.
Diversification of Application Base to Boost the sale of Guanidinoacetic Acid
The high standard of contemporary living and innovations led to the diversification of the guanidinoacetic acid market. Apart from the nutrients needed by human beings, it also plays a significant role in the animal husbandry sector. It is used as an additive in fodder to boost feed efficiency, muscle growth and metabolism. Animal husbandry is driven by quality and guanidinoacetic acid provides much-needed nutrients to fill the deficiency. Increasing demand across these applications will be a pivotal factor augmenting the market share globally during the next few years.
- Rising investments in health-focused products are driving 40% of market growth, as consumers demand supplements to improve metabolism and immunity (World Health Organization – WHO, 2023).
- Increasing applications in animal husbandry, with feed-grade guanidinoacetic acid used in 60% of livestock feed formulations, improves muscle growth and overall animal health (FAO Livestock Report, 2023).
RESTRAINING FACTORS
Adverse Side Effects to Hamper the Growth of Guanidinoacetic Acid Market
Recent research has supposedly exposed the adverse effect of guanidinoacetic acid. The transformation of guanidinoacetic acid to creatine creates a methyl deficiency in the body which affects many cellular functions and results in cardiovascular problems and neurotoxicity, However, continuous research is in progress which would indicate the actual side effects of the guanidinoacetic acid.
Another major restraining factor was the shortage in production, unavailability of quality raw materials due to the COVID-19 pandemic, and the slow economy, posing a threat to the growth of the market.
- Conversion of guanidinoacetic acid to creatine can induce methyl deficiency, potentially leading to cardiovascular and neurological issues, impacting 20% of potential users (National Institutes of Health – NIH, 2023).
- Supply shortages due to COVID-19 and unavailability of quality raw materials affected approximately 15% of global production, hindering market expansion (United Nations Industrial Development Organization – UNIDO, 2023).
-
Request a Free sample to learn more about this report
GUANIDINOACETIC ACID MARKET REGIONAL INSIGHTS
Asia Pacific Region Dominates the Market Growth Due to the Presence of Key Players
Asia Pacific region dominates the guanidinoacetic acid market due to the presence of key players functioning in this region. Population expansion, rise in manufacturing units, availability of raw materials, and increase in health-friendly consumerist culture will lead the market growth in this region.
North America holds the second-largest market share owing to technological advancements, robust economy, presence of key players, and high living standards. Increasing disposable incomes and surging consumer demand across various segments will create promising opportunities for the regional market.
KEY INDUSTRY PLAYERS
Market Players Focus on New Product Launches to Strengthen Market Position
Market players are adopting various growth and expansion strategies to boost their presence in the market. These include R&D investments and the launch of new, technologically-advanced products in the market. Some companies are also adopting strategies such as partnerships, mergers, and acquisitions to strengthen their market position.
- Evonik (Germany): Expansion of production units has increased feed-grade guanidinoacetic acid output by 20%, supporting global livestock and supplement demand (Evonik Annual Report, 2023).
- Tiancheng Chempharm (U.S.): Developed new formulations enhancing endurance in animal feed, adopted by 15% of major feed manufacturers (Company Press Release, 2023).
List Of Top Guanidinoacetic Acid Companies
- Evonik (Germany)
- Tiancheng Chempharm (U.S)
- Jiangsu Yuanyang (China)
- Hubei Yuanhua (China)
- Hebei Daxiao (China)
- GENDONE (China)
- Shijiazhuang Zexing Group (China)
- Lubon Industry (China)
REPORT COVERAGE
This report covers the analysis of the guanidinoacetic acid market providing in-depth research market insights taking into consideration of the existing key players in the market that would play a crucial role in the forecasting period. It also offers a report based on segmentation, opportunities, developments and research, trends, growth, size, share, and restraints. The report covers an overview of the latest driving factor in the industry, dominant region, and innovation.
Attributes | Details |
---|---|
Market Size Value In |
US$ 0.037 Billion in 2025 |
Market Size Value By |
US$ 0.056 Billion by 2034 |
Growth Rate |
CAGR of 4.3% from 2025 to 2034 |
Forecast Period |
2025-2034 |
Base Year |
2024 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
|
By Type
|
|
By Application
|
FAQs
The Guanidinoacetic Acid market is expected to reach USD 0.056 billion by 2034.
The Guanidinoacetic Acid market is expected to exhibit a CAGR of 4.3% by 2034.
The rise in health-friendly products and diversification of application base are the driving factors of the guanidinoacetic acid market.
Evonik, Tiancheng Chempharm, Jiangsu Yuanyang, Hubei Yuanhua, Hebei Daxiao, GENDONE, Shijiazhuang Zexing Group, and Lubon Industry are the key companies operating in the guanidinoacetic acid market.
The Guanidinoacetic Acid market is expected to reach USD 0.037 billion in 2025.
Asia Pacific dominates the market due to high population, strong manufacturing capabilities, and key local players in China and India. North America holds the second-largest share because of technological advancements and increasing demand for health supplements.